Knollwood Investment Advisory, LLC Bio N Tech Se Transaction History
Knollwood Investment Advisory, LLC
- $905 Billion
- Q1 2025
A detailed history of Knollwood Investment Advisory, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Knollwood Investment Advisory, LLC holds 5,479 shares of BNTX stock, worth $581,541. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,479
Previous 5,479
-0.0%
Holding current value
$581,541
Previous $624 Million
20.09%
% of portfolio
0.06%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$866 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$452 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$429 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$201 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$192 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...